Development of an optimized protocol for studying the interaction of filamentous bacteriophage with mammalian cells by fluorescence microscopy.

Microscopy Research and Technique
Gopal AbbineniChuanbin Mao

Abstract

Filamentous bacteriophage has been proposed as a vehicle that can carry and deliver therapeutics into mammalian cells for disease treatment, thus a protocol for imaging phage-cell interaction is essential. Because high signal intensity is necessary to study the mechanism of interaction between filamentous bacteriophage and mammalian cells, it is important to optimize the procedure for fluorescence labeling of phage in order to understand such interaction. Here, we describe a procedure that gives intense fluorescence labeling and can show interactions between fd-tet bacteriophage selected from phage libraries and mammalian cells (SKBR-3 and MCF-10A). The indirect labeling of phage with dye-conjugated antibody and cytoskeleton associated proteins was significantly enhanced in the presence of a cross-linking reagent called dithiobissuccinimidylpropionate (DSP) as shown by qualitative and quantitative fluorescence microscopy. The use of DSP resulted in high signal intensity in fluorescence imaging of phage-cell complex. The DSP cross-linker is believed to preserve soluble unbound proteins for fluorescence imaging. The interaction between the phage and mammalian cells was further confirmed by scanning electron microscopy.

References

Jan 1, 1986·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·H D Soule, C M McGrath
Mar 1, 1988·The Journal of Cell Biology·G RinnerthalerJ V Small
Mar 28, 1996·Nature·R Pasqualini, E Ruoslahti
Jun 1, 1996·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·B Safiejko-Mroczka, P B Bell
Jan 1, 1997·Annual Review of Biophysics and Biomolecular Structure·H B Lowman
Feb 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Wadih ArapErkki Ruoslahti
Apr 1, 1997·Chemical Reviews·George P. Smith, Valery A. Petrenko
Mar 26, 2003·Journal of Microbiological Methods·Charles L Turnbough
Nov 7, 2003·Applied and Environmental Microbiology·Jordan KnurrCharles L Turnbough
Jun 9, 2004·Drug Discovery Today·Robert C LadnerMark de Souza
Nov 23, 2006·Advanced Drug Delivery Reviews·Marianne Manchester, Pratik Singh
Jan 16, 2007·Neoplasia : an International Journal for Oncology Research·Kimberly A KellyRalph Weissleder
Jun 14, 2008·Biosensors & Bioelectronics·Hongying ZhuXudong Fan
Oct 22, 2008·Biochemical and Biophysical Research Communications·Lina EkerljungJohan Lennartsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.